Skip to content

Biotres

by Biotricity 2 variants

510(k) K222017

Biotres is a Class II device made by Biotricity, cleared under FDA 510(k) K222017 on 28 Jul 2022, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK222017 Date28 Jul 2022ClearedStatusActive

Official records

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
MWJ
Device class
Class II
Regulation
21 CFR Part 870.2800
Advisory committee
Cardiovascular
FDA decision
SESE Substantially Equivalent

Devices cleared under K222017

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K222017
UDI-DISize and differences
Biotres Pro 1.0
Biotricity, Inc.
1.0B635BIOTRESPR0 —On the market

Similar devices

Other devices filed under FDA product code MWJ (Electrocardiograph, Ambulatory (Without Analysis)).

Other devices from Biotricity, Inc.

See all devices from Biotricity, Inc. →